Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 104

1.

Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases.

Šimurina M, de Haan N, Vučković F, Kennedy NA, Štambuk J, Falck D, Trbojević-Akmačić I, Clerc F, Razdorov G, Khon A, Latiano A, D'Incà R, Danese S, Targan S, Landers C, Dubinsky M; IBD-BIOM consortium, McGovern DPB, Annese V, Wuhrer M, Lauc G.

Gastroenterology. 2018 Jan 5. pii: S0016-5085(18)30012-X. doi: 10.1053/j.gastro.2018.01.002. [Epub ahead of print]

PMID:
29309774
2.

IBD Serology and Disease Outcomes in African Americans With Crohn's Disease.

Bertha M, Vasantharoopan A, Kumar A, Bruce BB, Prince J, Hofmekler T, Okou D, Chopra P, Wang G, Sauer C, Landers CJ, Hussain SZ, Cross RK, Baldassano RN, Kappelman MD, Katz J, Alexander JS, Kirschner BS, Moulton DE, Osuntokun BO, Patel A, Saeed S, Klapproth JA, Dhere TA, Dubinsky MC, McGovern D, Kugathasan S.

Inflamm Bowel Dis. 2017 Dec 19;24(1):209-216. doi: 10.1093/ibd/izx021.

PMID:
29272484
3.

Protective role of γδ T cells in cigarette smoke and influenza infection.

Hong MJ, Gu BH, Madison MC, Landers C, Tung HY, Kim M, Yuan X, You R, Machado AA, Gilbert BE, Soroosh P, Elloso M, Song L, Chen M, Corry DB, Diehl G, Kheradmand F.

Mucosal Immunol. 2017 Nov 1. doi: 10.1038/mi.2017.93. [Epub ahead of print]

PMID:
29091081
4.

Multiplex CRISPR/Cas9-Based Genome Editing in Human Hematopoietic Stem Cells Models Clonal Hematopoiesis and Myeloid Neoplasia.

Tothova Z, Krill-Burger JM, Popova KD, Landers CC, Sievers QL, Yudovich D, Belizaire R, Aster JC, Morgan EA, Tsherniak A, Ebert BL.

Cell Stem Cell. 2017 Oct 5;21(4):547-555.e8. doi: 10.1016/j.stem.2017.07.015.

PMID:
28985529
5.

MicroRNA-22 controls interferon alpha production and erythroid maturation in response to infectious stress in mice.

Kadmon CS, Landers CT, Li HS, Watowich SS, Rodriguez A, King KY.

Exp Hematol. 2017 Dec;56:7-15. doi: 10.1016/j.exphem.2017.09.001. Epub 2017 Sep 11.

PMID:
28911907
6.

Colonic Phenotypes Are Associated with Poorer Response to Anti-TNF Therapies in Patients with IBD.

Yoon SM, Haritunians T, Chhina S, Liu Z, Yang S, Landers C, Li D, Ye BD, Shih D, Vasiliauskas EA, Ippoliti A, Rabizadeh S, Targan SR, Melmed GY, McGovern DPB.

Inflamm Bowel Dis. 2017 Aug;23(8):1382-1393. doi: 10.1097/MIB.0000000000001150.

PMID:
28590340
7.

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn's Disease.

Targan SR, Feagan B, Vermeire S, Panaccione R, Melmed GY, Landers C, Li D, Russell C, Newmark R, Zhang N, Chon Y, Hsu YH, Lin SL, Klekotka P.

Am J Gastroenterol. 2016 Nov;111(11):1599-1607. doi: 10.1038/ajg.2016.298. Epub 2016 Aug 2.

PMID:
27481309
8.

Outcomes with Anti-Tumour Necrosis Factor-Alpha Therapy and Serology in Patients with Denovo Crohn's Disease After Ileal Pouch Anal Anastomosis.

Robbins L, Zaghiyan K, Melmed G, Vasiliauskas E, Ahmed S, McGovern D, Rabizadeh S, Singh N, Landers C, Ippoliti A, Shih D, Targan S, Fleshner P.

J Crohns Colitis. 2017 Jan;11(1):77-83. doi: 10.1093/ecco-jcc/jjw134. Epub 2016 Jul 27.

PMID:
27466172
9.

TNFRSF1B Is Associated with ANCA in IBD.

Li D, Silverberg MS, Haritunians T, Dubinsky MC, Landers C, Stempak JM, Milgrom R, Guo X, Chen YD, Rotter JI, Taylor KD, McGovern DP, Targan SR.

Inflamm Bowel Dis. 2016 Jun;22(6):1346-52. doi: 10.1097/MIB.0000000000000771.

PMID:
27104820
10.

Allergen-encoded signals that control allergic responses.

Tung HY, Landers C, Li E, Porter P, Kheradmand F, Corry DB.

Curr Opin Allergy Clin Immunol. 2016 Feb;16(1):51-8. doi: 10.1097/ACI.0000000000000233. Review.

11.

Implementation of an inhaled nitric oxide protocol decreases direct cost associated with its use.

Todd Tzanetos DR, Housley JJ, Barr FE, May WL, Landers CD.

Respir Care. 2015 May;60(5):644-50. doi: 10.4187/respcare.03308. Epub 2015 Feb 3.

12.

Online survey as empathic bridging for the disenfranchised grief of pet loss.

Packman W, Carmack BJ, Katz R, Carlos F, Field NP, Landers C.

Omega (Westport). 2014;69(4):333-56. doi: 10.2190/OM.69.4.a.

PMID:
25304868
13.

IFNG rs1861494 polymorphism is associated with IBD disease severity and functional changes in both IFNG methylation and protein secretion.

Gonsky R, Deem RL, Landers CJ, Haritunians T, Yang S, Targan SR.

Inflamm Bowel Dis. 2014 Oct;20(10):1794-801. doi: 10.1097/MIB.0000000000000172.

14.

Multidimensional prognostic risk assessment identifies association between IL12B variation and surgery in Crohn's disease.

Dubinsky MC, Kugathasan S, Kwon S, Haritunians T, Wrobel I, Wahbeh G, Quiros A, Bahar R, Silber G, Farrior S, Stephens M, Teleten N, Panikkath D, Ippoliti A, Vasiliauskas E, Fleshner P, Williams C, Landers C, Rotter JI, Targan SR, Taylor KD, McGovern DP.

Inflamm Bowel Dis. 2013 Jul;19(8):1662-70. doi: 10.1097/MIB.0b013e318281f275.

15.

Markers of intestinal inflammation in patients with ankylosing spondylitis: a pilot study.

Matzkies FG, Targan SR, Berel D, Landers CJ, Reveille JD, McGovern DP, Weisman MH.

Arthritis Res Ther. 2012 Nov 29;14(6):R261. doi: 10.1186/ar4106.

16.

Pattern recognition receptor and autophagy gene variants are associated with development of antimicrobial antibodies in Crohn's disease.

Murdoch TB, Xu W, Stempak JM, Landers C, Targan SR, Rotter JI, Silverberg MS.

Inflamm Bowel Dis. 2012 Sep;18(9):1743-8. doi: 10.1002/ibd.22884. Epub 2012 Jan 24.

17.

Assessing inflammatory bowel disease-associated antibodies in Caucasian and First Nations cohorts.

Bernstein CN, El-Gabalawy H, Sargent M, Landers C, Rawsthorne P, Elias B, Targan SR.

Can J Gastroenterol. 2011 May;25(5):269-73.

18.

Combination of genetic and quantitative serological immune markers are associated with complicated Crohn's disease behavior.

Lichtenstein GR, Targan SR, Dubinsky MC, Rotter JI, Barken DM, Princen F, Carroll S, Brown M, Stachelski J, Chuang E, Landers CJ, Stempak JM, Singh S, Silverberg MS.

Inflamm Bowel Dis. 2011 Dec;17(12):2488-96. doi: 10.1002/ibd.21661. Epub 2011 Mar 9.

19.

High levels of Crohn's disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous disease.

Yu JE, De Ravin SS, Uzel G, Landers C, Targan S, Malech HL, Holland SM, Cao W, Harpaz N, Mayer L, Cunningham-Rundles C.

Clin Immunol. 2011 Jan;138(1):14-22. doi: 10.1016/j.clim.2010.08.003. Epub 2010 Oct 16.

20.

Distinct IFNG methylation in a subset of ulcerative colitis patients based on reactivity to microbial antigens.

Gonsky R, Deem RL, Landers CJ, Derkowski CA, Berel D, McGovern DP, Targan SR.

Inflamm Bowel Dis. 2011 Jan;17(1):171-8. doi: 10.1002/ibd.21352.

Supplemental Content

Loading ...
Support Center